Nichole Tripician Tanner

Title
InstitutionMedical University of South Carolina
DepartmentPulmonary
AddressP.O. Box MSC 630
Clinical Science Bldg. - 96 Jonathan Lucas St.
Phone843-792-0536
Fax843-876-2057
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Cancer/Lung, Pulmonary, Cancer, Lung

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Farjah F, Tanner NT. How I Do It: Mediastinal Staging for Lung Cancer. Chest. 2021 May 21. PMID: 34029567.
      Citations:    
    2. Tanner NT, Thomas NA, Ward R, Rojewski A, Gebregziabher M, Toll BA, Silvestri GA. Response. Chest. 2021 May; 159(5):2122. PMID: 33965149.
      Citations:    
    3. Silvestri GA, Bevill B, Chen A, Pastis NJ, Rivera MP, Tanner NT, Yarmus L, Vachani A. Response. Chest. 2021 01; 159(1):438-439. PMID: 33422209.
      Citations:    
    4. Tanner NT, Springmeyer SC, Porter A, Jett JR, Mazzone P, Vachani A, Silvestri GA. Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 Mar; 159(3):1283-1287. PMID: 33171158.
      Citations:    
    5. Tanner NT, Rivera MP. Improving Inequities in Lung Cancer Screening: Risk Prediction Models and the Potential to Achieve a Great Equalizer Effect. J Thorac Oncol. 2020 11; 15(11):1711-1713. PMID: 33148409.
      Citations:    
    6. Rivera MP, Katki HA, Tanner NT, Triplette M, Sakoda LC, Wiener RS, Cardarelli R, Carter-Harris L, Crothers K, Fathi JT, Ford ME, Smith R, Winn RA, Wisnivesky JP, Henderson LM, Aldrich MC. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 10 01; 202(7):e95-e112. PMID: 33000953.
      Citations:    
    7. Soneji S, Yang J, Tanner NT, Silvestri GA. Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681. PMID: 30852789.
      Citations:    
    8. Tanner NT, Thomas NA, Ward R, Rojewski A, Gebregziabher M, Toll BA, Silvestri GA. Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191. PMID: 32603713.
      Citations:    
    9. Fox AH, Tanner NT. Approaches to lung nodule risk assessment: clinician intuition versus prediction models. J Thorac Dis. 2020 Jun; 12(6):3296-3302. PMID: 32642253.
      Citations:    
    10. Tanner NT, Brasher PB, Wojciechowski B, Ward R, Slatore C, Gebregziabher M, Silvestri GA. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752. PMID: 32439505.
      Citations:    
    11. Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854. PMID: 32485147.
      Citations:    
    12. Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415. PMID: 32335067.
      Citations:    
    13. Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiol Imaging Cancer. 2020 05; 2(3):e204013. PMID: 33778716.
      Citations:    
    14. Thomas NA, Tanner NT. Lung Cancer Screening: Patient Selection and Implementation. Clin Chest Med. 2020 03; 41(1):87-97. PMID: 32008631.
      Citations:    
    15. Silvestri GA, Bevill BT, Huang J, Brooks M, Choi Y, Kennedy G, Lofaro L, Chen A, Rivera MP, Tanner NT, Vachani A, Yarmus L, Pastis NJ. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664. PMID: 31978428.
      Citations:    
    16. Tanner NT, Thomas NA, Ward R, Rojewski A, Gebregziabher M, Toll B, Silvestri GA. Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 Dec 01; 179(12):1710-1712. PMID: 31633739.
      Citations:    
    17. Burks AC, Gould MK, Silvestri G, Yarmus LB, Sears CR, Arenberg DA, Gonzalez AV, Slatore CG, Tanner NT, Vachani A, Nana-Sinkam P, Fuster MM, Wahidi MM, Tanoue LT, Rivera MP. Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362. PMID: 31437410.
      Citations:    
    18. Tanner NT, Brasher PB, Jett J, Silvestri GA. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98. PMID: 31732400.
      Citations:    
    19. Ward RC, Tanner NT, Silvestri GA, Gebregziabher M. Impact of Tobacco Dependence in Risk Prediction Models for Lung Cancer Diagnoses and Deaths. JNCI Cancer Spectr. 2019 Jun; 3(2):pkz014. PMID: 31360896.
      Citations:    
    20. Tanner NT, Banas E, Yeager D, Dai L, Hughes Halbert C, Silvestri GA. In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality. Chest. 2019 01; 155(1):236-238. PMID: 30616725.
      Citations:    
    21. Tanner NT, Silvestri GA. Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. Chest. 2019 01; 155(1):21-24. PMID: 30359617.
      Citations:    
    22. Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, Wahidi M, Shojaee S, Tanner NT, Callahan SP, Feldman G, Lorch DG, Ndukwu I, Pritchett MA, Silvestri GA. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146. PMID: 30292760.
      Citations:    
    23. Tanner NT, Yarmus L, Chen A, Wang Memoli J, Mehta HJ, Pastis NJ, Lee H, Jantz MA, Nietert PJ, Silvestri GA. Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043. PMID: 30144421.
      Citations:    
    24. Rivera MP, Tanner NT, Silvestri GA, Detterbeck FC, Tammemägi MC, Young RP, Slatore CG, Caverly TJ, Boyd CM, Braithwaite D, Fathi JT, Gould MK, Iaccarino JM, Malkoski SP, Mazzone PJ, Tanoue LT, Schoenborn NL, Zulueta JJ, Wiener RS. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13. PMID: 30004250.
      Citations:    
    25. Rojewski AM, Tanner NT, Dai L, Ravenel JG, Gebregziabher M, Silvestri GA, Toll BA. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118. PMID: 29793736.
      Citations:    
    26. Bade BC, Brasher PB, Luna BW, Silvestri GA, Tanner NT. Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43. PMID: 29433723.
      Citations:    
    27. Caverly TJ, Fagerlin A, Wiener RS, Slatore CG, Tanner NT, Yun S, Hayward R. Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project. JAMA Intern Med. 2018 03 01; 178(3):426-428. PMID: 29356812.
      Citations:    
    28. Silvestri GA, Tanner NT, Kearney P, Vachani A, Massion PP, Porter A, Springmeyer SC, Fang KC, Midthun D, Mazzone PJ. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500. PMID: 29496499.
      Citations:    
    29. Tanner NT, Dai L, Bade BC, Gebregziabher M, Silvestri GA. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608. PMID: 28722466.
      Citations:    
    30. Tanner NT, Porter A, Gould MK, Li XJ, Vachani A, Silvestri GA. Response. Chest. 2017 08; 152(2):448-449. PMID: 28797390.
      Citations:    
    31. Michaud GC, Channick CL, Caplan-Shaw C, Iaccarino JM, Slatore CG, Bade B, Tanner N, Robitaille C, Gonzalez AV, Goudie E, Liberman M, Sharma D, Shojaee S, Merrick CM, Maldonado F, Nguyen QL, Rivera-Lebron B, T Poston J. ATS Core Curriculum 2017: Part IV. Adult Pulmonary Medicine. Ann Am Thorac Soc. 2017 08; 14(Suppl_2):S196-S208. PMID: 28857625.
      Citations:    
    32. Soneji S, Yang J, Tanner NT, Dang R, Silvestri GA, Black W. Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. Am J Public Health. 2017 08; 107(8):1248-1250. PMID: 28700293.
      Citations:    
    33. Furukawa BS, Pastis NJ, Tanner NT, Chen A, Silvestri GA. Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of Respiration. Chest. 2018 01; 153(1):181-186. PMID: 28629919.
      Citations:    
    34. Tanner NT, Gould MK. Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It? Am J Respir Crit Care Med. 2017 06 15; 195(12):1556-1558. PMID: 28617083.
      Citations:    
    35. Soneji S, Tanner NT, Silvestri GA, Lathan CS, Black W. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597. PMID: 28450031.
      Citations:    
    36. Tanner NT, Pastis NJ. Chronic Obstructive Pulmonary Disease as a Lung Cancer Risk: Worth Its Weight in "GOLD". Ann Am Thorac Soc. 2017 03; 14(3):309-310. PMID: 28248590.
      Citations:    
    37. Kinsinger LS, Anderson C, Kim J, Larson M, Chan SH, King HA, Rice KL, Slatore CG, Tanner NT, Pittman K, Monte RJ, McNeil RB, Grubber JM, Kelley MJ, Provenzale D, Datta SK, Sperber NS, Barnes LK, Abbott DH, Sims KJ, Whitley RL, Wu RR, Jackson GL. Implementation of Lung Cancer Screening in the Veterans Health Administration. JAMA Intern Med. 2017 03 01; 177(3):399-406. PMID: 28135352.
      Citations:    
    38. Ravenel JG, Tanner NT, Silvestri GA. Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. Chest. 2017 03; 151(3):525-526. PMID: 28279269.
      Citations:    
    39. Gesthalter YB, Koppelman E, Bolton R, Slatore CG, Yoon SH, Cain HC, Tanner NT, Au DH, Clark JA, Wiener RS. Evaluations of Implementation at Early-Adopting Lung Cancer Screening Programs: Lessons Learned. Chest. 2017 07; 152(1):70-80. PMID: 28223153.
      Citations:    
    40. Tanner NT, Porter A, Gould MK, Li XJ, Vachani A, Silvestri GA. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270. PMID: 28115167.
      Citations:    
    41. Kanodra NM, Pope C, Halbert CH, Silvestri GA, Rice LJ, Tanner NT. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982. PMID: 27676369.
      Citations:    
    42. Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74. PMID: 27387658.
      Citations:    
    43. Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, Egede LE, Silvestri GA. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41. PMID: 26502000.
      Citations:    
    44. Tanner NT, Aggarwal J, Gould MK, Kearney P, Diette G, Vachani A, Fang KC, Silvestri GA. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414. PMID: 26087071.
      Citations:    
    45. Tanner NT, Silvestri GA, Fccp MD. Rebuttal From Drs Tanner and Silvestri. Chest. 2015 Dec; 148(6):1379-1380. PMID: 26110565.
      Citations:    
    46. Tanner NT, Silvestri GA. POINT: Is N2 Disease a Contraindication for Surgical Resection for Superior Sulcus Tumors? Yes. Chest. 2015 Dec; 148(6):1373-1375. PMID: 26110373.
      Citations:    
    47. Tanner NT, Silvestri GA. What's in a Number? When It Comes to Pulmonary Nodules, It's All About the Number. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1149-50. PMID: 26568237.
      Citations:    
    48. Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015 Oct 01; 192(7):881-91. PMID: 26426785.
      Citations:    
    49. Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8. PMID: 25928649.
      Citations:    
    50. Tanner NT, Silvestri GA. Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1. PMID: 25978569.
      Citations:    
    51. Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10. PMID: 25978579.
      Citations:    
    52. Kanodra NM, Silvestri GA, Tanner NT. Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56. PMID: 25641734.
      Citations:    
    53. Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33. PMID: 25369325.
      Citations:    
    54. Bade B, Furukawa B, Tanner NT. Convex probe endobronchial ultrasound. Semin Respir Crit Care Med. 2014 Dec; 35(6):636-44. PMID: 25463155.
      Citations:    
    55. Vachani A, Tanner NT, Aggarwal J, Mathews C, Kearney P, Fang KC, Silvestri G, Diette GB. Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91. PMID: 25386795.
      Citations:    
    56. Pastis NJ, Vanderbilt AA, Tanner NT, Silvestri GA, Huggins JT, Svigals Z, Shepherd RW. Construct validity of the Simbionix bronch mentor simulator for essential bronchoscopic skills. J Bronchology Interv Pulmonol. 2014 Oct; 21(4):314-21. PMID: 25321450.
      Citations:    
    57. Mehta HJ, Tanner NT, Silvestri G, Simkovich SM, Shamblin C, Shaftman SR, Nietert PJ, Yang J. Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7. PMID: 25186645.
      Citations:    
    58. Pastis NJ, Greer TJ, Tanner NT, Wahlquist AE, Gordon LL, Sharma AK, Koch NC, Silvestri GA. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411. PMID: 24577678.
      Citations:    
    59. Mehta HJ, Nietert PJ, Tanner NT, Ravenel JG, Silvestri GA. Response. Chest. 2014 Aug; 146(2):e70. PMID: 25091775.
      Citations:    
    60. Mehta HJ, Ravenel JG, Shaftman SR, Tanner NT, Paoletti L, Taylor KK, Tammemagi MC, Gomez M, Nietert PJ, Gould MK, Silvestri GA. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472. PMID: 23949741.
      Citations:    
    61. Tanner NT, Silvestri GA. Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749. PMID: 24297115.
      Citations:    
    62. Tanner NT, Egede LE, Shamblin C, Gebregziabher M, Silvestri GA. Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787. PMID: 23764896.
      Citations:    
    63. Skouras VS, Tanner NT, Silvestri GA. Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med. 2013 Dec; 34(6):762-9. PMID: 24258566.
      Citations:    
    64. Hsia DW, Tanner NT, Shamblin C, Mehta HJ, Silvestri GA, Musani AI. The latest generation in flexible bronchoscopes: a description and evaluation. J Bronchology Interv Pulmonol. 2013 Oct; 20(4):357-62. PMID: 24162125.
      Citations:    
    65. Gilbert CR, Chen A, Akulian JA, Lee HJ, Wahidi M, Argento AC, Tanner NT, Pastis NJ, Harris K, Sterman D, Toth JW, Chenna PR, Feller-Kopman D, Yarmus L. The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study. Pediatr Pulmonol. 2014 Aug; 49(8):807-15. PMID: 24039186.
      Citations:    
    66. Tanner NT, Pastis NJ, Silvestri GA. Training for linear endobronchial ultrasound among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest. 2013 Feb 01; 143(2):423-428. PMID: 22878834.
      Citations:    
    67. Tanner NT, Silvestri GA. Lung cancer screening with low-dose CT: benefits and potential risks. Evid Based Med. 2013 Jun; 18(3):108-9. PMID: 23086387.
      Citations:    
    68. Tanner NT, Sherman CA, Silvestri GA. Biomarkers in the selection of maintenance therapy in non-small cell lung cancer. Transl Lung Cancer Res. 2012 Jun; 1(2):96-8. PMID: 25806163.
      Citations:    
    69. Tanner NT, Mehta H, Silvestri GA. New testing for lung cancer screening. Oncology (Williston Park). 2012 Feb; 26(2):176-82. PMID: 22489353.
      Citations:    
    70. Tanner NT, Gomez M, Rainwater C, Nietert PJ, Simon GR, Green MR, Silvestri GA. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9. PMID: 22237260.
      Citations:    
    71. Tanner NT, Pastis NJ, Sherman C, Simon GR, Lewin D, Silvestri GA. The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7. PMID: 22176813.
      Citations:    
    72. Tanner NT, Watson P, Boylan A, Memoli JS, Pastis N, Taylor K, Garrett-Mayer E, Silvestri GA. Utilizing endobronchial ultrasound with fine-needle aspiration to obtain tissue for molecular analysis: a single-center experience. J Bronchology Interv Pulmonol. 2011 Oct; 18(4):317-21. PMID: 23208625.
      Citations:    
    73. Wang Memoli JS, El-Bayoumi E, Pastis NJ, Tanner NT, Gomez M, Huggins JT, Onicescu G, Garrett-Mayer E, Armeson K, Taylor KK, Silvestri GA. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556. PMID: 21636663.
      Citations:    
    74. Tanner NT, Silvestri GA. An up to date look at lung cancer screening. Cell Adh Migr. 2010 Jan-Mar; 4(1):96-9. PMID: 20139695.
      Citations:    
    75. Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, Pirker R. Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010 Jan; 15(1):44-50. PMID: 20199634.
      Citations:    
    76. Tanner NT, Gomez M, Silvestri GA. Denture misadventure: an unusual cause of hemoptysis. J Bronchology Interv Pulmonol. 2009 Jul; 16(3):216-8. PMID: 23168559.
      Citations:    
    77. Gomez M, Tanner NT, Recavarren RA, Ravenel J, Silvestri GA. A 79-year-old woman with a right paratracheal mass. Chest. 2009 May; 135(5):1384-1388. PMID: 19420209.
      Citations:    
    Tanner's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (226)
    Explore
    _
    Co-Authors (21)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _